Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP?1 Market?
Source: Motley Fool
2026-03-06 18:25:00 ET
Is Novo Nordisk (NYSE: NVO) a bargain or a value trap as it battles Eli Lilly (NYSE: LLY) for GLP?1 leadership, execution credibility, and premium growth? Watch the video below to see how investors might navigate this high?stakes rivalry.
*This video was published on Feb. 24, 2026.
Eli Lilly and Company
NASDAQ: LLY
LLY Trading
2.2% G/L:
$1001.12 Last:
1,205,353 Volume:
$986.89 Open:
LLY Latest News
LLY Stock Data
$977,526,804,738
935,929,919
9.81%
2658
N/A
Pharmaceuticals
Healthcare
US
Indianapolis
